Hematology

A new therapeutic agent added to standard of care significantly improves outcomes for patients with serious complication of systemic lupus erythematosus.

The FDA has approved a new option for the treatment of HIV-1 in adults as a replacement for current antiretroviral regimens in patients who are virologically suppressed and with no history of treatment...

The FDA has approved a new option for the treatment of HIV-1 in adults as a replacement for current antiretroviral regimens in patients who are virologically suppressed and with no history of treatment...

The FDA released a letter to clinical providers warning that several molecular tests for COVID-19 may result in false negatives and offers recommendations.

The approval comes as part of the FDA’s mission to bring lower-cost, high-quality generic drug products to market.

This roundup of recent FDA approvals details the authorization of a new COVID-19 vaccine and options for lung and prostate cancer.

This roundup of recent FDA approvals details the authorization of a new COVID-19 vaccine and options for lung and prostate cancer.

This roundup of recent FDA approvals details the authorization of a new COVID-19 vaccine and options for lung and prostate cancer.

In an emergency use authorization, the FDA has approved a new COVID-19 home test for use with a prescription.

The US Food and Drug Administration has issued an emergency use authorization for a rapid, lateral flow antigen test that is the first over-the-counter at-home diagnostic test for COVID-19.